Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1241.70

-13.00 (-1.04%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1241.70

-13.00 (-1.04%)
16:02 Dec 20

Quality

77/100
High Financial Strength

Valuation

58/100
Affordable Valuation

Technical

48/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	24774.62	23455.49	24855.38	29001.87	30295.02
Operating Expenses +	19441.22	19068.72	21136.74	23158.87	23835.19
Raw Material	10632.68	9323.6	11702.94	13549.07	13507.65
Increase Decrease in Cost	-730.21	816.68	-409.68	-946.17	-1013.25
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	3535.02	3450.92	3522.25	3922.94	4197.43
Miscellaneous Expenses	10634.57	9381.06	10422.09	12178.89	7143.36
Operating Profit	5333.4	4386.77	3718.64	5843	6459.83
Other Income	380.85	320.35	290.59	557.38	655.07
Depreciation	1055.39	1126.52	1244.58	1521.66	1564.06
Interest	74.49	48.64	140.48	289.71	388.72
Profit before tax and exceptio..	4584.37	3531.96	2624.17	4589.01	5162.12
Exceptional Items	2814.58	-127.97	0	-191.86	-122.11
PBT	7398.95	3403.99	2624.17	4397.15	5284.23
Provision for Taxation	2009.77	725.63	684.85	1211.02	1441.18
Net Profit	5389.18	2678.36	1939.32	3186.13	3598.83
NET Profit after MI	5334.84	2648.15	1927.5	3172.97	3581.64
EPS	91.05	45.19	32.9	54.16	61.24
Operating Profit Margin (%)	21.53	18.7	14.96	20.15	21.32
Net Profit Margin (%)	21.53	11.29	7.75	10.94	11.82

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	51.80	51.80	51.80	51.80	51.80
FII	16.60	16.70	18.00	20.70	22.40
MF	18.50	19.20	17.80	14.70	11.30
Public	6.40	6.70	6.90	6.80	7.40
Others	0.10	0.00	0.00	0.10	0.10
Others	6.60	5.60	5.50	5.90	7.00